Literature DB >> 33985614

Review of infective dose, routes of transmission and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses- CORRIGENDUM.

Sedighe Karimzadeh1, Raj Bhopal2, Huy Nguyen Tien3.   

Abstract

Entities:  

Year:  2021        PMID: 33985614      PMCID: PMC8129670          DOI: 10.1017/S0950268821001084

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


× No keyword cloud information.
The original version of the article published with errors in Table 2. For clarity, the corrected version of this table is shown below
Table 2.

Experimental studies on the infective dose of coronaviruses in various mammals

VirusHostDose (PFU)Route of inoculationNumbers and/or %, signs of infectionReferences
SARS-CoV-2aFerret221 359IN6/6Kim [16]
500IN16.7,1/6Ryan [17]
50 000IN6/6
5 000 000IN6/6
420 000IN4/4Richard [18]
SARS-CoV-2 HCoV-OC43bhACE2 mice70 000IN36.8,7/19Bao [19]
400 000IN3/3Sun [20]
4 000 000IG1/3
630Aerosol2/2Bao [21]
21 000IN50% LethalJiang [22]
100 000IN40% LethalDinnon [23]
BALB/c mice16 000IN3/3Gu [24]
BALB/c and C57B6 mice70 000IP/IC100% LethalJacomy [25]
BALB/c mice70IC100% LethalShen [26]
SARS-CoV-1tgMice280INNRWatanabe [8]
MERS-CoVtgMice0.7INNRTao [27]
7IN50% Lethal
SARS-CoV-2cCynomolgus macaques48 600Aerosol4/4Johnston [28]
700 000IN/IT4/4Rockx [29]
SARS-CoV-2dRhesus macaques700 000IO2/2Deng [30]
IT1/1
IG0/2
1 820 000IN/IT/IO/Oral8/8Munster [31]
11 000IN/IT3/3Chandrashekar [32]
110 000IN/IT3/3
1 100 000IN/IT3/3
28 700Aerosol4/4Johanston [28]
SARS-CoV-2eAfrican green monkeys38 000Aerosol3/3Johanston [28]
500 000IN/IT6/6Woolsey [33]
3 000 000IN6/6Cross [34]
2000Aerosol2/2Blair [35]
3 610 000IO/IT/IN/Oral2/2
SARS-CoV-2fSyrian hamster398 107IN/IO4/4Imai [36]
1000IN/IO4/4
56 000IN3/3Sia [37]
100 000IN75,24/36Osterrieder [38]
Immunocompromised syrian hamster100IN10/10Brocato [39]
1000IN
10 000IN40% Lethal
gBats70 000IN78,7/9Schlottau [40]

TCID50, %50 tissue infective culture dose; PFU, plaque-forming units; tgMice, transgenic mice; hACE2, human angiotensin converting enzyme 2, BALB/c; begg albino laboratory-bred mouse, IN; intranasal, IG; intragastric, IO; intraocular, IT; intrathecal, IC; intracerebral, IP; intraperitoneal, NR; not reported.

Experimental studies on the infective dose of coronaviruses in various mammals TCID50, %50 tissue infective culture dose; PFU, plaque-forming units; tgMice, transgenic mice; hACE2, human angiotensin converting enzyme 2, BALB/c; begg albino laboratory-bred mouse, IN; intranasal, IG; intragastric, IO; intraocular, IT; intrathecal, IC; intracerebral, IP; intraperitoneal, NR; not reported. One of the authors’ names was also formatted incorrectly. The correct name is Nguyen Tien Huy. This has now been updated in the original article.
  1 in total

1.  Review of infective dose, routes of transmission, and outcome of COVID-19 caused by the SARS-COV-2: comparison with other respiratory viruses.

Authors:  Sedighe Karimzadeh; Raj Bhopal; Nguyen Tien Huy
Journal:  Epidemiol Infect       Date:  2021-04-14       Impact factor: 2.451

  1 in total
  3 in total

1.  A population framework for predicting the proportion of people infected by the far-field airborne transmission of SARS-CoV-2 indoors.

Authors:  Christopher Iddon; Benjamin Jones; Patrick Sharpe; Muge Cevik; Shaun Fitzgerald
Journal:  Build Environ       Date:  2022-06-18       Impact factor: 7.093

2.  Modelling airborne transmission of SARS-CoV-2 at a local scale.

Authors:  Simon Rahn; Marion Gödel; Gerta Köster; Gesine Hofinger
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

3.  Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic.

Authors:  Claudia Blaurock; Angele Breithaupt; Saskia Weber; Claudia Wylezich; Markus Keller; Björn-Patrick Mohl; Dirk Görlich; Martin H Groschup; Balal Sadeghi; Dirk Höper; Thomas C Mettenleiter; Anne Balkema-Buschmann
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.